ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment

Immune checkpoint inhibitors (ICIs) have shown promising results in bladder cancer (BC). However, only some patients respond to ICIs. DNA repair defects (DDR) play an important role in the therapeutic response of bladder cancer. Therefore, we aimed to elucidate the association between ICIs in bladde...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Ruibin, Lin, Anqi, Cao, Manming, Xu, Abai, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456912/
https://www.ncbi.nlm.nih.gov/pubmed/32922441
http://dx.doi.org/10.3389/fgene.2020.00933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456912/
https://www.ncbi.nlm.nih.gov/pubmed/32922441
http://dx.doi.org/10.3389/fgene.2020.00933

Ejemplares similares